有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Habekacin;Arbekacin;Habekacin
Chemical Name 1-N-[(S)-4-Amino-2-hydroxybutyryl]dibekacin;1-N-[(S)-4-Amino-2-hydroxybutyryl]-3,4-dideoxykanamycin B;O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1--4)-O-[2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1--6)]-N-[(2S)-4-amino-2-hydroxybutyryl]-2-deoxy-L-streptamine
CAS 51025-85-5
Related CAS 75282-65-4 (carbonate(1:2) salt)
Formula C22H44N6O10
Structure
Formula Weight 552.63018
Stage 上市-1990
Company Meiji Seika (Originator)
Activity/Mechanism Antibiotics, ANTIINFECTIVE THERAPY, Aminoglycosides
Syn. Route 5
Route 1
the acylation of 3,4-dideoxykanamycin b (dibekacin) (i) with n-benzyloxycarbonyloxysuccinimide (ii) and zinc acetate in dmso gives 3,2,6-tri-n-benzyloxycarbonydibekacin (iii), which is then treated with the n-hydroxysuccinimide ester of 2-hydroxy-4-aminobutyric acid (iv) and finally deprotected by hydrogenation with h2 over pd/c in acidic water dioxane.
List of intermediates No.
(4-chlorophenyl)methanesulfonyl chloride (i)
(ii)
(iii)
(iv)
Reference 1:
    umezawa, h.; umezawa, s.; tsuchiya, t.; takagi, y.; jikihara, t. (microbial chemistry research foundation); production of a selectively protected n-acylated derivative of an aminoglycosidic antibiotic. be 0879925; de 2945010; fr 2441631; fr 2482109; gb 2036020; gb 2065123; jp 80164696; jp 8064598; us 4297485 .
Reference 2:
    serradell, m.n.; castaner, j.; blancafort, p.; habekacin. drugs fut 1983, 8, 5, 410.

Route 2
the acylation of 3,4-dideoxykanamycin b (dibekacin) (i) with benzyloxycarbonyl chloride in water gives 6-n-benzyloxycarbonyldibekacin (v), which is then acylated with (iv) as before and deprotected by hydrogenolysis with h2 over pd/c in water - acetic acid.
List of intermediates No.
[5-[3-benzoyl-2,4-dioxo-5-vinyl-3,4-dihydro-1(2h)-pyrimidinyl]-3-(benzoyloxy)tetrahydro-2-furanyl]methyl benzoate
(4-chlorophenyl)methanesulfonyl chloride (i)
(iv)
(v)
Reference 1:
    umezawa, h.; umezawa, s.; maeda, k.; tsuchiya, o.; kondo, s.; fukatsu, s. (microbial chemistry research foundation); 1-n-[(s)-alpha-hydroxy-omega-aminoacyl]. de 2530169; fr 2201875; gb 1426908; jp 7462442; jp 7480039; jp 7494648; jp 7733629; jp 8003357; us 4001208; us 4107424 .
Reference 2:
    serradell, m.n.; castaner, j.; blancafort, p.; habekacin. drugs fut 1983, 8, 5, 410.

Route 3
the acylation of 3,2,6-tri-n-benzyloxycarbonydibekacin (iii) with ethyl trifluoroacetate and k2co3 gives 3,2,6-tri-n-benzyloxycarbonyl-3-trifluoroacetyldibekacin (vi), which is acylated again with (iv) yielding the protected habekacin (vii). finally, this compound is deprotected by hydrolysis with ammonia in aqueous thf, followed by hydrogenolysis with h2 over pd/c.
List of intermediates No.
(4-chlorophenyl)methanesulfonyl chloride (i)
(ii)
(iii)
(iv)
5-iodo-3-thiophenecarbaldehyde (vi)
(5-iodo-3-thienyl)methanol (vii)
Reference 1:
    tsuchiya, t.; takagi, y.; umezawa, s.; 1-n-acylation of aminocyclitol antibiotics via zinc chelation and regiospecific n-trifluoroacetylation. tetrahedron lett 1979, 51, 4951-54.
Reference 2:
    serradell, m.n.; castaner, j.; blancafort, p.; habekacin. drugs fut 1983, 8, 5, 410.

Route 4
the acylation of 3,4-dideoxykanamycin b (dibekacin) (i) with tert-butyl-s-(4,6-dimethylpyrimid-2-yl)thiocarbonate (viii) by means of triethylamine in isopropanol gives 3,2,6-tri-n-tert-butyloxycarbonyldibekacin (ix), which is acylated again with 4-benzyloxycarbonylamino-2-hydroxybutyric acid n-hydroxysuccinimide ester (x) in the yielding the protected habekacin (xi). finally, this compound is deprotected by a treatment with trifluoroacetic acid, followed by hydrogenolysis with h2 over pd/c in methanol - acetic acid.
List of intermediates No.
(4-chlorophenyl)methanesulfonyl chloride (i)
(viii)
(ix)
(x)
(xi)
Reference 1:
    umezawa, h.; kondo, s. (microbial chemistry research foundation); process for the preparation of 1-n-isoseryl- or 1-n-(l-4-amino-2-hydroxybutyryl)-3,4-dideoxykanamycin b and intermediates thereof. de 2950020; fr 2444046; gb 2038329; gb 2072676; gb 2072677; jp 55081897; us 4268664 .
Reference 2:
    serradell, m.n.; castaner, j.; blancafort, p.; habekacin. drugs fut 1983, 8, 5, 410.

Route 5
the acylation of 3,4-dideoxy-3,4-didehydrokanamycin b (xii) with tert-butyl-s-(4,6-dimethylpyrimid-2-yl)thiocarbonate (viii) as before gives 3,2,6-tri-n-butoxycarbonyl-3,4-dideoxy-3,4-didehydrokanamycin b (xiii), which is acylated again with (x) as before yielding the fully protected 3,4-didehydrohabekacin (xiv). partial deprotection of (xiv) with trifluoroacetic acid affords 1-n-(4-benzyloxycarbonylamino-2-hydroxybutyryl)-3,4-dideoxy-3,4-didehydrokanamycin b (xv), which is finally debenzylated and reduced by a treatment with h2 over pto2 in aqueous acetic acid.
List of intermediates No.
(viii)
(x)
(xii)
(xiii)
(5r,6s)-6-[4-(propylsulfonyl)-1,2,5-thiadiazol-3-yl]-1-azabicyclo[3.2.1]octane; 4-[(5r,6s)-1-azabicyclo[3.2.1]oct-6-yl]-1,2,5-thiadiazol-3-yl propyl sulfone (xiv)
4-[(5r,6s)-1-azabicyclo[3.2.1]oct-6-yl]-1,2,5-thiadiazole-3-thiol; 4-[(5r,6s)-1-azabicyclo[3.2.1]oct-6-yl]-1,2,5-thiadiazol-3-ylhydrosulfide (xv)
Reference 1:
    serradell, m.n.; castaner, j.; blancafort, p.; habekacin. drugs fut 1983, 8, 5, 410.

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名阿贝卡星;英文名Habekacin;Arbekacin;Habekacin;CAS[51025-85-5]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
江苏地区粗苯价格暂稳
山东地区粗苯价格暂稳
华东地区丁二烯市场弱势盘整
浙江省化学农药使用量连续7年持
华东地区丁二烯市场价格走低
兴发集团实现草甘膦副产物高效高
华北地区BDO市场弱势延续
华南地区己二酸行情持稳
红太阳/丰山集团等8家农药生产
中国农民礼赞!——写在第一个“
我国化工园区第一个国家标准已获
浙江地区二氯甲烷价格暂稳
2018年智能制造试点示范项目
2018年秋播小麦种子药剂处理
内蒙古元正精细化工高效氟吡甲禾
农业农村部农药检定所征求《农药
刘学:浅析农药登记后再评价工作
华北地区丁二烯市场行情弱势
江西地区二氯甲烷价格暂稳
新安股份前三季度业绩预增,净利
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明